The diagnosis and management of asymptomatic primary hyperparathyroidism

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 9, 2006, Pages 494-503

  Silverberg, Shonni J ^a   Bilezikian, John P ^a,b  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Hyperparathyroidism; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CINACALCET; PHOSPHATE; RALOXIFENE;

BONE DENSITOMETRY; BONE DISEASE; CARDIOVASCULAR DISEASE; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; ESTROGEN THERAPY; GASTRINOMA; HEALTH CARE ORGANIZATION; HUMAN; HYPERCALCEMIA; KIDNEY DISEASE; NEPHROLITHIASIS; NEUROMUSCULAR DISEASE; NEUROPSYCHIATRY; NEUROPSYCHOLOGY; OSTEOLYSIS; PANCREATITIS; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PEPTIC ULCER; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; UNITED STATES;

BONE DISEASES; CARDIOVASCULAR DISEASES; DIPHOSPHONATES; ESTROGENS; GASTROINTESTINAL DISEASES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; NAPHTHALENES; PARATHYROID GLANDS; PHOSPHATES; RENAL INSUFFICIENCY;

EID: 33748462857     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0265     Document Type: Review

References (82)

1. Albright F and Reifenstein EC (1948) The Parathyroid Glands and Metabolic Bone Disease. Baltimore: Williams and Wilkins
2. Heath H et al. (1980) Primary hyperparathyroidism incidence, morbidity and potential economic impact in a community. N Eng J Med 302: 189-193
3. Silverberg SJ and Bilezikian JP (2001) Clinical presentation of primary hyperparthyroidism in the United States. In The Parathyroids, edn 2, 349-360 (Eds Bilezikian JP et al.) New York: Academic Press
4. Silverberg SJ et al. (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107: 561-567
5. Silverberg SJ et al. (2003) Clinical utility of an immunoradiometric assay for whole PTH (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 88: 4725-4730
6. Silverberg SJ and Bilezikian JP (2003) "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab 88: 5348-5352
7. Shane E (2001) Parathyroid carcinoma. In The Parathyroids, edn 2, 515-526 (Eds Bilezikian JP et al.) New York: Academic Press
8. Arnold A et al. (2002) Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17 (Suppl 2): N30-N36
9. Arnold A et al. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J Clin Invest 83: 2034-2040
10. Farnebo F et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83: 2627-2630
11. Cetani F et al. (1999) No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 14: 878-882
12. Shattuck TM et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Eng J Med 349: 1722-1729
13. Carpten JD et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32: 676-680
14. Krebs LJ et al. (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90: 5015-5017
15. Mithal A et al. (2001) Clinical presentation of primary hyperparthyroidism: India, Brazil and China. In The Parathyroids, edn 2, 375-386 (Eds Bilezikian JP et al.) New York: Academic Press
16. Silverberg SJ et al. (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4: 283-291
17. Parisien MV et al. (1990) The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 70: 930-938
18. Silverberg SJ et al. (1996) Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81: 4007-4012
19. Dempster DW (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84: 1562-1566
20. Adami S et al. (1998) Bone measurements in primary hyperparathyroidism. Bone 22: 565-570
21. Parfitt AM (2003) Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17: 1741-1743
22. Vestergaard P et al. (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321: 598-602
23. Khosla S et al. (1999) Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Miner Res 14: 1700-1707
24. Wilson RJ et al. (1988) Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109: 959-962
25. Silverberg SJ et al. (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341: 1249-1255
26. Silverberg SJ et al. (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89: 327-334
27. Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17 (Suppl 2): N87-N94
28. Tsien R (1990) Calcium channels in the cardiovascular system. In Cardiac Electrophysiology, 75-90 (Eds Rosen M et al.) Mt Kisco: Futura
29. Symons C et al. (1985) Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism-an association. Br Heart J 54: 539-542
30. Roberts WC and Waller BF (1981) Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 71: 371-384
31. Silverberg SJ (2002) Non-classical target organs in hyperparathyroidism. J Bone Miner Res 17 (Suppl 2): N117-N125
32. Hedback G and Oden A (1998) Increased risk of death from PHPT-an update. Eur J Clin Invest 28: 271-276
33. Nilsson IL et al. (2002) Clinical presentation of PHPT in Europe-nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17 (Suppl 2): N68-N74
34. Vestergaard P et al. (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27: 216-222
35. Wermers RA et al. (1998) Survival after diagnosis of PHPT: a population based study. Am J Med 104: 115-122
36. Broulik PD et al. (1985) Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy. Exp Clin Endocrinol 86: 346-352
37. Bradley EL and Wells JO (1983) Primary hyperparathyroidism and hypertension. Am Surg 49: 569-570
38. Stefenelli T et al. (1993) Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95: 197-202
39. Stefenelli T et al. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82: 106-112
40. Piovesan A et al. (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50: 321-328
41. Nilsson IL et al. (2001) Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 130: 986-990
42. Nilsson IL et al. (1999) Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126: 1049-1055
43. Neunteufl TR (1998) Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40: 396-401
44. Smith JC et al. (2000) Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 85: 3515-3519
45. Rubin MR et al. (2005) Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 90: 3326-3330
46. Patten BM et al. (1974) The neuromuscular disease of hyperparathyroidism. Ann Intern Med 80: 182-194
47. Vicale CT (1949) Diagnostic features of muscular syndrome resulting from hyperparathyroidism, osteomalacia owing to renal tubular acidosis and perhaps to related disorders of calcium metabolism. Trans Am Neurol Assoc 74: 143-147
48. Turken SA et al. (1989) Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87: 553-557
49. Clark OH (1994) "Asymptomatic" primary hyperparathyroidism: is parathyroidectomy indicated? Surgery 116: 947-953
50. Pasieka JL and Parsons L (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22: 513-519
51. Burney RE et al. (1999) Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125: 608-614
52. Talpos GB et al. (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey. Surgery 128: 1013-1020
53. Quiros RM et al. (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134: 675-681
54. Chiang CY et al. (2005) A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin Endocrinol (Oxf) 62: 99-104
55. Jensen RT (1998) Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Int Med 243: 477-488
56. Brandi ML et al. (2001) Consensus Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658-5671
57. Bess MA et al. (1980) Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243: 246-247
58. Kondo Y et al. (1998) Primary hyperparathyroidism and acute pancreatitis during pregnancy. Int J Pancreatol 24: 43-47
59. Bilezikian JP et al. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17 (Suppl 2): N2-N11
60. Silverberg SJ et al. (2002) Youthfulness as a criterion for surgery in primary hyperparathyroidism. Am J Med 113: 681-684
61. Alveryd A (1968) Parathyroid glands in thyroid surgery. I. Anatomy of parathyroid glands. II. Postoperative hypoparathyroidism-identification and autotransplantation of parathyroid glands. Acta Chir Scand 389: 1-120
62. Akerstrom G et al. (1984) Surgical anatomy of human parathyroid glands. Surgery 95: 14-21
63. Wang CA (1976) The anatomic basis of parathyroid surgery. Ann Surg 183: 271-275
64. Wei JP et al. (1994) Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans. Ann Surg 219: 568-572
65. Norton JA (2006) Surgical management of hyperparathyroidism. In Endocrinology, edn 5 (vol 2), 1583-1594 (Eds DeGroot LJ and Jameson JL) Philadelphia: WB Saunders
66. Ogilvie JB and Clark OH (2005) Parathyroid surgery: we still need traditional and selective approaches. J Endocrinol Invest 28: 566-569
67. Miccoli P (2005) Parathyroid surgery: we only need a minimal surgical approach. J Endocrinol Invest 28: 570-573
68. Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235: 665-672
69. Irvin GL III et al. (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229: 874-878
70. Chen H et al. (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138: 583-587
71. Wells SA Jr et al. (1980) Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192: 451-458
72. Locker FG et al. (1997) Optimal dietary calcium intake in primary hyperparathyroidism. Am J Med 102: 543-550
73. Marcus R (2002) The role of estrogens and related compounds in the management of primary hyperparathyroidism. J Bone Min Res 17 (Suppl 2): N146-N149
74. Grey AB et al. (1996) Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. Ann Intern Med 125: 360-368
75. Rubin MA et al. (2003) Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 1174-1178
76. Parker CR et al. (2002) Alendronate in the treatment of primary hyperparathyroidism-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 87: 4482-4489
77. Chow CC et al. (2003) Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 581-587
78. Kahn AA et al. (2004) Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89: 3319-3325
79. Shoback DM et al. (2003) The calcimimetic AMG 073 normalizes serum calcium in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 5644-5649
80. Peacock M et al. (2003) Long term control of primary hyperparathyroidism with cinacalcet HCl. J Bone Miner Res 18 (Suppl 2): S16
81. Cope O (1966) The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 21: 1174-1182
82. Mallette LE et al. (1974) Primary hyperparathyroidism: clinical and biochemical features. Medicine 53: 127-146